Background Topical steroid-dependent or damaged face (TSDF) is a common condition where the widespread availability of over-the-counter topical corticosteroid (TCS)-containing products leads to their misuse and addiction. Prolonged use of these steroids on the face can result in significant side effects. Early diagnosis and cessation of steroid use are important. Dermoscopy can serve as an easy-to-use and non-invasive tool for the early diagnosis and for assessing the exact extent of damage caused by steroid misuse. Aims and objectives To observe the various clinical and demographic features of patients with TSDF, the dermoscopic features of these patients, and to find their association with the potency and duration of application of TCS. Material and methods In this observational, cross-sectional study of 250 patients (aged 12-60 years, both genders) presenting with facial dermatosis and clinical signs of TSDF, having a history of at least one month of TCS use, were enrolled using consecutive sampling. Demographic data, clinical features, and dermoscopic findings were recorded. Dermoscopic results were compared with clinical examination, TCS potency, and duration of application. Results The majority (208; 83.2%) of the patients were females, and most of them belonged to the age group of 26-35 years (87; 34.8%). Hyperpigmentation (101; 40.4%) was the most prevalent indication for TCS use in the study. The most common clinical findings included erythema, hypertrichosis, and telangiectasia. Dermoscopic findings such as linear, serpentine, polygonal, and Y-shaped vessels, along with breaking of the pseudo reticular network, red diffuse areas, Demodex tails, and comedones were significantly associated with the duration of TCS use. Linear vessels, Demodex tails, and comedones also correlated significantly with TCS potency, while most other findings did not. Conclusion Dermoscopy is a novel, non-invasive diagnostic technique for the early identification of TCS abuse. In TSDF, it confirms the diagnosis and predicts disease severity earlier than examination by the naked eye alone.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11680711 | PMC |
http://dx.doi.org/10.7759/cureus.74624 | DOI Listing |
JAMA Netw Open
January 2025
Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, Massachusetts.
Importance: CHEK2 pathogenic and likely pathogenic variants (PVs) are common, and low-risk (LR) variants, p.I157T, p.S428F, and p.
View Article and Find Full Text PDFJAMA Netw Open
January 2025
Medical Oncology, The Ottawa Hospital Cancer Centre, University of Ottawa Faculty of Medicine, Ottawa, Ontario, Canada.
Importance: Evolving breast cancer treatments have led to improved outcomes but carry a substantial financial burden. The association of treatment costs with the cost-effectiveness of screening mammography is unknown.
Objective: To determine the cost-effectiveness of population-based breast cancer screening in the context of current treatment standards.
JAMA Netw Open
January 2025
Department of Epidemiology, University of Texas MD Anderson Cancer Center, Houston.
Importance: Cardiovascular disease (CVD) and cancer are the leading causes of mortality in the US. Large-scale population-based and mechanistic studies support a direct effect of CVD on accelerated tumor growth and spread, specifically in breast cancer.
Objective: To assess whether individuals presenting with advanced breast cancers are more likely to have prevalent CVD compared with those with early-stage breast cancers at the time of diagnosis.
J Acquir Immune Defic Syndr
January 2025
Centre for Infectious Disease Epidemiology and Research, School of Public Health, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Background: Data on tuberculosis (TB) incidence and risk factors among children living with HIV (CLHIV) in the universal ART era are limited.
Methods: We analysed routinely-collected data on TB diagnoses for CLHIV age ≤5 years, born 2018-2022, in the Westen Cape, South Africa. We examined factors associated with TB diagnosis, with death and loss to follow-up as competing events.
World J Pediatr
January 2025
The First Hospital of Peking University, Beijing, China.
Background: Glucose transporter 1 deficiency syndrome (Glut1DS) was initially reported by De Vivo and colleagues in 1991. This disease arises from mutations in the SLC2A1 and presents with a broad clinical spectrum. It is a treatable neuro-metabolic condition, where prompt diagnosis and initiation of ketogenic dietary therapy can markedly enhance the prognosis.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!